Curtis, L D <br/><br/>
Pharmacokinetics and pharmacodynamics of BB-10153, a thrombin-activatable plasminogen, in healthy volunteers.  [electronic resource] 

 -  Journal of thrombosis and haemostasis : JTH  Jun 2005 
 - 1180-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1538-7933 
<br/><br/><label>Standard No.: </label>10.1111/j.1538-7836.2005.01352.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Area Under Curve<br/>Double-Blind Method<br/>Fibrin Fibrinogen Degradation Products<br/>Fibrinogen--drug effects<br/>Fibrinolysis<br/>Half-Life<br/>Humans<br/>Male<br/>Pharmacokinetics<br/>Plasminogen--administration & dosage<br/>Thrombin--metabolism<br/>alpha-2-Antiplasmin--drug effects